These drugs will be entering in their global Phase -3 clinical trials early next year.
Data also show that several other leading domestic pharma companies have recalled their products from the US
'We lost our place in being first in the epidemic, when it hit India so hard, but we were actually the epicentre of the epidemic from essentially April 2020, for almost an entire year. We had such high cases. We were the country that had the most mixed response.'
The Maharashtra Food and Drug Administration has ordered withdrawal of Amulspray from Mumbai with immediate effect.
Maharashtra government on Friday decided to put a ban on Maggi noodles after some samples were found to contain lead above the permissible limit.
The worms were detected in Elferri capsules, manufactured by a Goan company. The FDA has initiated a probe.
Global generic drugs producer Sandoz has opened its third plant in India at Navi Mumbai with annual production capacity of one billion tablets and capsules.
As the global debate on booster shots gathers momentum, several scientists in New Delhi said the priority must be to ensure that more people are inoculated with at least their first jab.
Illustrious international thinkers met at the Milken Institute Global Conference 2021 and many discussions addressed the impact of the COVID-19 pandemic on the world at large.
If the company manages to get a go-ahead from the regulator for this plant, it might result in resumption of supplies of several of their products, barred from the US last year.
Riluzole is indicated for the treatment of amyotrophic lateral sclerosis.
The US Food and Drug Administration has asked USV to probe employees who might have been responsible for inaccurate data reporting.
market, was today seized from an illegal drug manufacturing unit in Jalgaon district in north Maharashtra and six persons were arrested, Directorate of Revenue Intelligence officials said.
'India is too large a place to have just 10 labs performing these Covid-19 tests.'
Of the 23 Indian billionaires mentioned in the Bloomberg Billionaires Index, only one saw a reduction in net worth, with the companies owned by most of them outperforming the Nifty 50 index by a big margin.
The introduction of e-pharmacy, to protect the interest of a handful of players, would hamper the interest of 800,000 chemists and 80 lakh workers and their families
Kapiva's plans to introduce allopathy-like doses of ayurvedic remedies for the millennial consumer finds traction.
Its Waluj manufacturing facility in Maharashtra failed to meet the good manufacturing norms prescribed by the UK drug regulator.
In its daily briefing, the government also reported Goa is now free of coronavirus.
We are surrounded by food that is contaminated, adulterated and does not meet Indian safety and packaging standards, says Abheet Singh Sethi/IndiaSpend.com.
Investment in market leaders with a safety-first approach could yield reasonable returns across sectors.
An International Policy Network report in 2010 found that seven per cent of drugs bought from wholesale traders were substandard, and 3.6 per cent of the drugs from traders contained no active ingredient whatsoever.
Sun Pharmaceutical, which is growing its dermatology and ophthalmic specialty business in the US will spend $460 million on R&D.
Nestle now has less than two weeks to convince the regulator why product approval for its noodles should not be withdrawn
It hopes to turn around Ranbaxy within four years of closing the deal by improving efficiency and resolving all regulatory issues
The S&P BSE Sensex ended down 371 points at 24,966 and the Nifty50 closed 101 points lower at 7,615.
According to market experts, GST Bill, movement of the rupee and uncertain global cues amid expected rate cut by the US Fed will dictate the movement of the markets.
The joint entity will have a market share of nine per cent in India. Analysts tracking the company said one of the key outcomes of the merger would be to create a single brand entity of Sun and the Ranbaxy brand would eventually dissolve.
In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
Benchmark indices finished higher on hopes of economic reforms
The S&P BSE Sensex gained 115 points to end at 24,338 and the Nifty50 climbed 42 points to close at 7,404.
Mumbai-based serial entrepreneur Shreekant Pawar, who is all set to launch a device to help fight diabetes tells us more about the lessons he's learned in the journey
Nestl is facing its worst crisis ever. Can it learn from its peers?
The Sensex ended below 28,000 for the second straight day at 27,869.
'There are different kinds of risk.' 'It is a very powerful value. Your ability to de-risk the risk is also as important for risk taking.'
Currently, Himalaya sells 250 products across the globe.
'We have created an enemy we can't even see and that enemy is entertaining us while tightening the noose around our necks.' 'As the radiation increases, it will affect everything -- from your little bumble bee to plants to every living cell.' 'By the time the effects are understood, it might be too late.'
